Pindolol
- Generic Name
- Pindolol
- Brand Names
- Viskazide, Visken
- Drug Type
- Small Molecule
- Chemical Formula
- C14H20N2O2
- CAS Number
- 13523-86-9
- Unique Ingredient Identifier
- BJ4HF6IU1D
- Background
Pindolol is a first generation non-selective beta blocker used in the treatment of hypertension. Early research into the use of pindolol found it had chronotropic effects, and so further investigation focused on the treatment of arrhythmia. Research into pindolol's use in the treatment of hypertension began in the early 1970s.
...
- Indication
Pindolol is indicated in the management of hypertension. In Canada, it is also indicated in the prophylaxis of angina.
- Associated Conditions
- Angina Pectoris, Atrial Fibrillation, Depression, Hypertension
- Associated Therapies
- -
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
- Conditions
- Interventions
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2024-10-16
- Target Recruit Count
- 47
- Registration Number
- NCT01950520
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand Preparations
- Conditions
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 30
- Registration Number
- NCT01400165
- Locations
- 🇨🇦
University of Ottawa, Institute of Mental Health Research, Ottawa, Ontario, Canada
Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2009-07-02
- Target Recruit Count
- 30
- Registration Number
- NCT00931775
- Locations
- 🇪🇸
Outpatients Service of Psychiatry Department. Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)
- Conditions
- Interventions
- First Posted Date
- 2009-05-08
- Last Posted Date
- 2009-06-15
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 16
- Registration Number
- NCT00895804
- Locations
- 🇨🇭
Heffter Research Center, University Hospital of Psychiatry, Zurich, Switzerland
Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris
- Conditions
- Interventions
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2009-05-06
- Lead Sponsor
- University of Aarhus
- Target Recruit Count
- 10
- Registration Number
- NCT00424801
- Locations
- 🇩🇰
Aarhus Hospital, Aarhus, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.